Biodegradable laminar implants for sustained release of recombinant human growth hormone

Biomaterials

Volumn 23, Issue 24, 2002, Pages 4759-4764

  García, Juan T ^a   Dorta, M Jesús ^a   Munguía, Obdulia ^a   Llabrés, Matías ^a   Fariña, José B ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Body weight; Laminar implant; Organ weights; RhGH; Tibia dimensions

Indexed keywords

BIODEGRADATION; BIOLOGICAL ORGANS; HORMONES; TOXICITY; WEIGHING;

SUBCUTANEOUS INJECTIONS;

IMPLANTS (SURGICAL);

HUMAN GROWTH HORMONE; POLYGLACTIN; RECOMBINANT HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIODEGRADABLE IMPLANT; BODY WEIGHT; CONTROLLED STUDY; DRUG HALF LIFE; INTERMETHOD COMPARISON; MALE; NEPHROTOXICITY; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE; TIBIA; TREATMENT OUTCOME;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; BODY WEIGHT; BONE SUBSTITUTES; HUMAN GROWTH HORMONE; HUMANS; KINETICS; LACTIC ACID; MALE; ORGAN SIZE; POLYGLYCOLIC ACID; POLYMERS; RATS; RECOMBINANT PROTEINS; TIBIA; TIME FACTORS;

EID: 0036888473     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(02)00225-9     Document Type: Article

References (13)

1. Katakam M., Ravis W.R., Golden D.L., Banga A.K. Controlled release of human growth hormone following subcutaneous administration in dogs. Int J Pharm. 152:1997;53-58.
2. Brodbeck K.J., Pushpala S., Mchugh A.J. Release of human growth hormone from PLGA solution depots. Pharm Res. 16(2):1999;1825-1829.
3. Johnson O.L., Cleland J.L., Lee H.J., Charnis M., Duenas E., Jaworowicz W., Shepard D., Shahzamani A., Jones A.J.S., Putney S.D. A month-long effect from single injection of microencapsulated human growth hormone. Nature Med. 2(7):1996;795-799.
4. Cleland J.L., Duenas E., Daugherty A., Marian M., Yang J., Wilson M., Celniker A.C., Shahzamani A., Quarmby V., Chu H., Mukku V., Mac A., Roussakis M., Gillette B.B., Yeung D., Brooks D., Maa Y.-F., Hsu C., Jones A.J.S. Recombinant human growth hormone poly(lactic-co-glycolic acid) PLGA microspheres provide a long lasting effect. J Control Rel. 49:1997;193-205.
5. Reiter E.O., Attie K.M., Moshang T. Jr., Silverman B.L., Kemp S.F., Neuwirth R.B., Ford K.M., Saenger P. Genentech, Inc.-Alkermes, Inc. Collaborative Study Group. A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiency. J Clin Endocrinol Metab. 86(10):2001;4700-4706.
6. Gilding D.K., Reed A.M. Biodegradable polymers for use in surgery polyglycolic/polylactic homo and copolymers. Polymer. 20:1979;1459-1464.
7. Dorta M.J., Munguía O., Llabrés M. Effects of polymerization variables on PLGA propiertes. molecular weight, composition and chain structure Int J Pharm. 100:1993;9-14.
8. Glynn P.A.R., Van der Hoff B.M.E., Reilly P.M. A general model for prediction of molecular weight distributions of degraded polymers development and comparison with ultrasonic degradation experiments. J Macromol Sci Chem. A6:1976;1653-1664.
9. International Conference on Harmonization (ICH) of Technical Requeriments for the Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures: Methodology (ICH-Q2B), 1996.
10. Thakkar AL, Harrison RG, Moore DL. Injectable sustained release formulations. US Patent No. 4997659, 1998.
11. Battersby J., Clark R., Hancock W., Puchulu-Campanella E., Haggart N., Poll D., Harding D. Sustained release of recombinant human growth hormone from dextran via hydrolysis of an imine bond. J Control Rel. 42:1996;143-156.
12. European Pharmacopeia. Part II, Vol. 7, 2nd Ed. Ministerio de Sanidad y Consumo editors, Madrid, España, 1987.
13. Van Buul-Offers S., Van der Brande J.L. Biosynthetic human growth hormone. effects on growth of snell dwarf mice Horm Metabol Res. 17:1985;20-24.